Galpharm 4-In-One Flu Relief Powder For Oral Solution
Galpharm 4-In-One Flu Relief powder for oral solution
Patient Information Leaflet
Read all of this leaflet carefully before you take this medicine because it contains important information you need to know.
This medicine is available without prescription, however, you still need to use this product carefully to get the best results from it. Keep this leaflet as you may need to read it again. Ask your pharmacist if you need more information or advice.
This medicine contains:
• paracetamol which is a pain reliever (analgesic) and helps reduce your temperature when you have a fever
• guaifenesin which is an expectorant to help loosen phlegm
• phenylephrine which is a decongestant to reduce swelling in the passages of the nose to help you breathe more easily
• cetylpyridinium chloride which is an antibacterial, and relieves sore throats.
These sachets are used for the short term relief of the symptoms of colds and flu, including aches and pains, headache, blocked nose, tickly sore throat and chesty coughs.
Do not take this medicine if you:
• are allergic to paracetamol, guaifenesin, phenylephrine, cetylpyridinium chloride or any of the other ingredients
• have a serious heart condition or cardiovascular disorder(s)
• have high blood pressure (hypertension)
• have an overactive thyroid
• have glaucoma
• have difficulty passing urine
• are taking antidepressant drugs called monoamine oxidase inhibitors (MAOI’s), or have taken them within the last 14 days - these are medicines such as phenelzine, isocarboxazid and tranylcypromines are currently taking other decongestant drugs (e.g. ephedrine and xylometazoline) or stimulants (e.g. dexamfetamine).
• are pregnant or breastfeeding
• suffer from kidney or liver problems, including alcoholic liver disease
• have diabetes
• have circulatory disorders such as a condition called Raynaud’s Phenomenon, which results from poor circulation in the fingers and toes
• have angina
• have an enlarged prostate gland, as this may cause more difficulty in passing urine
• suffer from phenylketonuria, a rare, inherited metabolic disorder.
• medicines to treat high cholesterol levels which reduce the amount of fat in the blood such as colestyramine
• medicines to control feeling sick or being sick such as metoclopramide or domperidone
• medicines called anti-coagulants, which are used to thin the blood such as warfarin or other coumarins - you may take occasional doses of paracetamol but should consult your doctor if you need to take it on a regular basis
• barbiturates (for epilepsy or to help you sleep), such as phenobarbitones
• tricyclic antidepressants such as imipramine, amitriptyline
• medicines to treat heart or circulatory problems, or to lower blood pressure, (e.g. digoxin, guanethidine, reserpine, methyldopa)
• beta blockers (e.g. atenolol) or vasodilators (e.g. hydralazine)
• phenothiazines used as sedatives (e.g. chlorpromazine, pericyazine and fluphenazine)
• if you are going to have a general anaesthetic as this may cause changes in heart rhythm.
If you are taking medication or are under medical care, consult your doctor before using this medicine.
Long term use of this product is not recommended.
Contains aspartame (E951), a source of phenylalanine equivalent to 20 mg per sachet. May be harmful for people with phenylketonuria.
Each sachet contains 117 mg sodium. To be taken into consideration by people on a controlled sodium diet.
Pour the contents of 1 sachet into a standard mug. Fill the mug to below the brim with approximately 250 ml (8 fluid oz) of hot, but not boiling, water. Stir until dissolved, and allow to cool to a drinkable temperature.
1 sachet every 4 hours, as required. Do not take more than 4 sachets (4 doses) in any 24 hour period.
Do not exceed the stated dose. If your symptoms persist or worsen, you must see a doctor or pharmacist.
Immediate medical advice should be sought in the event of an overdose, even if you feel well, because of the risk of delayed, serious liver damage.
Go to your nearest hospital casualty department. Take your medicine and this leaflet with you.
Most people do not have any side effects while taking this medicine. However, if you experience any of the following side effects, or anything else unusual happens, stop taking the medicine immediately, and see your doctor or pharmacist.
Rare side effects are:
• allergic reactions such as skin rash
• stomach upsets, diarrhoea
• tingling and coolness of the skin
• difficulty sleeping (insomnia)
• nervousness, tremors or convulsions
• a rise in body temperature
• a rise in blood pressure with headache, vomiting (being sick) and fast, slow or irregular heart beat (palpitations).
More rarely, the following side effects can happen:
• you may become more prone to bleeding, bruising, fever and infections, such as sore throat and ulcers, due to changes in your blood.
Very rare cases of serious skin reactions have been reported.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.
Keep all medicines out of the reach and sight of children.
Do not use this medicine after the expiry date which is stated on the carton and sachet. The expiry date refers to the last day of that month.
Do not store above 25°C.
Each 3.54 g sachet of off-white powder, taken as a hot drink, contains the active ingredients: paracetamol 500 mg, guaifenesin 200 mg, phenylephrine hydrochloride 10 mg and cetylpyridinium chloride 3 mg.
The other ingredients are: maltodextrin, citric acid (anhydrous), tartaric acid, sodium citrate, acesulfame potassium (E950), aspartame (E951), powdered menthol flavour, lemon flavour and the colour curcumin (E100).
This product is available in pack sizes of 5 or 10 sachets.
The Marketing Authorisation holder and manufacturer is Perrigo, Braunton, Devon, EX33 2DL, UK.
Text Revised: September 2015
<Please insert Perrigo component number here>